Table 1. Select demographic and clinical characteristics (n=1,917).
| Characteristics | Values | |
|---|---|---|
| Median age (yr) | 68 | |
| Stage | ||
| Localized | 1,359 (70.9) | |
| Regional | 419 (21.9) | |
| Distant | 139 (7.3) | |
| Tumor size (cm) | ||
| <2 | 605 (31.6) | |
| 2–3.9 | 402 (21.0) | |
| ≥4 | 298 (15.5) | |
| Size unknown | 612 (31.9) | |
| Race | ||
| White | 1,800 (93.9) | |
| Black | 62 (3.2) | |
| Other | 55 (2.9) | |
| CDCC score | ||
| 0 | 1,524 (79.5) | |
| 1 | 307 (16.0) | |
| 2 | 69 (3.6) | |
| ≥3 | 17 (0.9) | |
| Insurance | ||
| Not insured | 45 (2.3) | |
| Private Insurance | 730 (38.1) | |
| Medicaid | 64 (3.3) | |
| Medicare | 1,028 (53.6) | |
| Other government | 10 (0.5) | |
| Unknown | 40 (2.1) | |
| Median income quartiles | ||
| <$38,000 | 262 (13.8) | |
| $38,000–$47,999 | 456 (24.0) | |
| $48,000–$62,999 | 552 (29.1) | |
| $63,000+ | 629 (33.1) | |
| % of adults in patient zip code with no high school degree | ||
| ≥21.0 | 251 (13.2) | |
| 13.0–20.9 | 467 (24.6) | |
| 7.0–12.9 | 674 (35.5) | |
| <7.0 | 508 (26.7) | |
| Year of diagnosis | ||
| 2004–2007 | 467 (24.4) | |
| 2008–2011 | 652 (34.0) | |
| 2012–2015 | 798 (41.6) | |
| Region | ||
| Northeast | 375 (19.6) | |
| Midwest | 487 (25.4) | |
| South | 628 (32.8) | |
| West | 427 (22.3) | |
| Facility type | ||
| Academic | 854 (44.5) | |
| Non-academic | 1,063 (55.5) | |
| County population | ||
| Metro | 1,508 (81.6) | |
| Urban | 304 (16.5) | |
| Rural | 36 (1.9) | |
| Surgery | ||
| No | 95 (5.0) | |
| Yes | 1,822 (95.0) | |
| Radiation | ||
| No | 1,718 (89.6) | |
| Yes | 199 (10.4) | |
| Chemotherapy | ||
| No | 1,815 (94.7) | |
| Yes | 102 (5.3) | |
| Immunotherapy | ||
| No | 1,727 (90.1) | |
| Yes | 190 (9.9) | |
Values are presented as number (%).
CDCC, Charlson/Deyo comorbidity.